Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Nebacumab

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J06BC01

CAS registry number (Chemical Abstracts Service)

0138661-01-5

Therapeutic Category

Immunomodulator

Chemical Name

Immunoglobulin M (human monoclonal HA-1A anti-endotoxin), disulfide with human monoclonal HA-1A kappa-chain, pentameric dimer (WHO)

Foreign Names

  • Nebacumabum (Latin)
  • Nebacumab (German)
  • Nebacumab (French)
  • Nebacumab (Spanish)

Generic Names

  • Nebacumab (OS: BAN, USAN)
  • Nébacumab (OS: DCF)
  • Antiendotoxin monoclonal antibody (IS)
  • HA-1A (IS)
  • Septomonab (IS)
  • Xomen-E5 (IS)

Brand Name

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide